CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Masco Group now a major stakeholder of Swedish company, KeyPlants AB

Masco Group now a major stakeholder...

How AIin Biotech and PharmaceuticalImpacts Drug Discovery

How AIin Biotech and...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a...

Masco Group now a major stakeholder of Swedish company, KeyPlants AB

Masco Group now a major stakeholder...

How AIin Biotech and PharmaceuticalImpacts Drug Discovery

How AIin Biotech and...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a...

Myriad Genetics And Epic Join Forces To Expand Access To Genetic Testing For More Patients

Life Sciences Review | Monday, July 04, 2022
Tweet

The partnership between Myriad Genetics and Epic will facilitate the expansion of Myriad's customer-centric, technology-enabled commercial capabilities through over 600 EHR integrations.


Fremont, CA: “Our collaboration with Epic reflects our strategy to partner with other healthcare industry leaders so we can advance precision medicine together. Increasing access to genetic insights and integrating our tests into Epic's vast network of healthcare systems represents a significant step forward to better serve patients and healthcare providers," comments Paul J. Diaz, president, and CEO, of Myriad Genetics. Myriad Genetics, an industry leader in genetic testing and precision medicine, has collaborated with Epic, the top healthcare software company, to connect Myriad's comprehensive array of genetic tests with Epic's vast network of 600,000 clinicians and more than 250 million patients.


The connection enables a smooth, end-to-end workflow solution for healthcare providers to order Myriad testing and evaluate findings without additional stages or manual ordering. Epic facilitates the secure transmission of patient information across healthcare organizations.


 


With the ability to evaluate pertinent health information, order tests, and receive findings natively within Epic, doctors will have access to the genetic insights and related information necessary to improve health outcomes and the patient experience. In addition, patients will have easy access to their Myriad test results and other health information via their EHR site.


As part of its transformation and growth strategy, Myriad is emphasizing the development of customer-centric, technology-enabled products that simplify genetic testing for patients and physicians. With the recent introduction of Myriads Precise Oncology Solutions, providers may now submit a single order for several Myriad tests and obtain rapid results via a centralized web platform. Now, through the agreement with Epic, Myriad is expanding its efforts to enable clinicians and health organizations to gain faster and more convenient access to genetic testing within their existing platform.


“Genetic testing and precision medicine save lives,” states Alan Hutchison, vice president of Population Health at Epic. “Through this relationship, were bringing genetic insights to the point of care at scale, giving providers and patients the information they need to make more timely, informed decisions.”


Weekly Brief

loading
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/myriad-genetics-and-epic-join-forces-to-expand-access-to-genetic-testing-for-more-patients--nwid-864.html